Literature DB >> 26286987

Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination.

J Zachary Sanborn1, Jongsuk Chung2, Elizabeth Purdom3, Nicholas J Wang4, Hojabr Kakavand5, James S Wilmott5, Timothy Butler6, John F Thompson7, Graham J Mann5, Lauren E Haydu5, Robyn P M Saw7, Klaus J Busam8, Roger S Lo9, Eric A Collisson10, Joe S Hur11, Paul T Spellman6, James E Cleaver12, Joe W Gray4, Nam Huh2, Rajmohan Murali13, Richard A Scolyer7, Boris C Bastian14, Raymond J Cho12.   

Abstract

Melanoma is difficult to treat once it becomes metastatic. However, the precise ancestral relationship between primary tumors and their metastases is not well understood. We performed whole-exome sequencing of primary melanomas and multiple matched metastases from eight patients to elucidate their phylogenetic relationships. In six of eight patients, we found that genetically distinct cell populations in the primary tumor metastasized in parallel to different anatomic sites, rather than sequentially from one site to the next. In five of these six patients, the metastasizing cells had themselves arisen from a common parental subpopulation in the primary, indicating that the ability to establish metastases is a late-evolving trait. Interestingly, we discovered that individual metastases were sometimes founded by multiple cell populations of the primary that were genetically distinct. Such establishment of metastases by multiple tumor subpopulations could help explain why identical resistance variants are identified in different sites after initial response to systemic therapy. One primary tumor harbored two subclones with different oncogenic mutations in CTNNB1, which were both propagated to the same metastasis, raising the possibility that activation of wingless-type mouse mammary tumor virus integration site (WNT) signaling may be involved, as has been suggested by experimental models.

Entities:  

Keywords:  genetics; melanoma; metastasis

Mesh:

Year:  2015        PMID: 26286987      PMCID: PMC4568214          DOI: 10.1073/pnas.1508074112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  The life history of 21 breast cancers.

Authors:  Serena Nik-Zainal; Peter Van Loo; David C Wedge; Ludmil B Alexandrov; Christopher D Greenman; King Wai Lau; Keiran Raine; David Jones; John Marshall; Manasa Ramakrishna; Adam Shlien; Susanna L Cooke; Jonathan Hinton; Andrew Menzies; Lucy A Stebbings; Catherine Leroy; Mingming Jia; Richard Rance; Laura J Mudie; Stephen J Gamble; Philip J Stephens; Stuart McLaren; Patrick S Tarpey; Elli Papaemmanuil; Helen R Davies; Ignacio Varela; David J McBride; Graham R Bignell; Kenric Leung; Adam P Butler; Jon W Teague; Sancha Martin; Goran Jönsson; Odette Mariani; Sandrine Boyault; Penelope Miron; Aquila Fatima; Anita Langerød; Samuel A J R Aparicio; Andrew Tutt; Anieta M Sieuwerts; Åke Borg; Gilles Thomas; Anne Vincent Salomon; Andrea L Richardson; Anne-Lise Børresen-Dale; P Andrew Futreal; Michael R Stratton; Peter J Campbell
Journal:  Cell       Date:  2012-05-17       Impact factor: 41.582

2.  SomaticSniper: identification of somatic point mutations in whole genome sequencing data.

Authors:  David E Larson; Christopher C Harris; Ken Chen; Daniel C Koboldt; Travis E Abbott; David J Dooling; Timothy J Ley; Elaine R Mardis; Richard K Wilson; Li Ding
Journal:  Bioinformatics       Date:  2011-12-06       Impact factor: 6.937

3.  Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.

Authors:  Nikhil Wagle; Caroline Emery; Michael F Berger; Matthew J Davis; Allison Sawyer; Panisa Pochanard; Sarah M Kehoe; Cory M Johannessen; Laura E Macconaill; William C Hahn; Matthew Meyerson; Levi A Garraway
Journal:  J Clin Oncol       Date:  2011-03-07       Impact factor: 44.544

4.  β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas.

Authors:  William E Damsky; David P Curley; Manjula Santhanakrishnan; Lara E Rosenbaum; James T Platt; Bonnie E Gould Rothberg; Makoto M Taketo; David Dankort; David L Rimm; Martin McMahon; Marcus Bosenberg
Journal:  Cancer Cell       Date:  2011-12-13       Impact factor: 31.743

Review 5.  Clinical implications of cancer self-seeding.

Authors:  Elizabeth Comen; Larry Norton; Joan Massagué
Journal:  Nat Rev Clin Oncol       Date:  2011-04-26       Impact factor: 66.675

6.  Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells.

Authors:  Anja Ulmer; Oleg Schmidt-Kittler; Jörg Fischer; Ulf Ellwanger; Gernot Rassner; Gert Riethmüller; Gerhard Fierlbeck; Christoph A Klein
Journal:  Clin Cancer Res       Date:  2004-01-15       Impact factor: 12.531

7.  Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs.

Authors:  Christopher T Saunders; Wendy S W Wong; Sajani Swamy; Jennifer Becq; Lisa J Murray; R Keira Cheetham
Journal:  Bioinformatics       Date:  2012-05-10       Impact factor: 6.937

8.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.

Authors:  Rosandra N Kaplan; Rebecca D Riba; Stergios Zacharoulis; Anna H Bramley; Loïc Vincent; Carla Costa; Daniel D MacDonald; David K Jin; Koji Shido; Scott A Kerns; Zhenping Zhu; Daniel Hicklin; Yan Wu; Jeffrey L Port; Nasser Altorki; Elisa R Port; Davide Ruggero; Sergey V Shmelkov; Kristian K Jensen; Shahin Rafii; David Lyden
Journal:  Nature       Date:  2005-12-08       Impact factor: 49.962

9.  Whole genome sequencing of matched primary and metastatic acral melanomas.

Authors:  Samra Turajlic; Simon J Furney; Maryou B Lambros; Costas Mitsopoulos; Iwanka Kozarewa; Felipe C Geyer; Alan Mackay; Jarle Hakas; Marketa Zvelebil; Christopher J Lord; Alan Ashworth; Meirion Thomas; Gordon Stamp; James Larkin; Jorge S Reis-Filho; Richard Marais
Journal:  Genome Res       Date:  2011-12-19       Impact factor: 9.043

10.  Whole-genome analysis informs breast cancer response to aromatase inhibition.

Authors:  Matthew J Ellis; Li Ding; Dong Shen; Jingqin Luo; Vera J Suman; John W Wallis; Brian A Van Tine; Jeremy Hoog; Reece J Goiffon; Theodore C Goldstein; Sam Ng; Li Lin; Robert Crowder; Jacqueline Snider; Karla Ballman; Jason Weber; Ken Chen; Daniel C Koboldt; Cyriac Kandoth; William S Schierding; Joshua F McMichael; Christopher A Miller; Charles Lu; Christopher C Harris; Michael D McLellan; Michael C Wendl; Katherine DeSchryver; D Craig Allred; Laura Esserman; Gary Unzeitig; Julie Margenthaler; G V Babiera; P Kelly Marcom; J M Guenther; Marilyn Leitch; Kelly Hunt; John Olson; Yu Tao; Christopher A Maher; Lucinda L Fulton; Robert S Fulton; Michelle Harrison; Ben Oberkfell; Feiyu Du; Ryan Demeter; Tammi L Vickery; Adnan Elhammali; Helen Piwnica-Worms; Sandra McDonald; Mark Watson; David J Dooling; David Ota; Li-Wei Chang; Ron Bose; Timothy J Ley; David Piwnica-Worms; Joshua M Stuart; Richard K Wilson; Elaine R Mardis
Journal:  Nature       Date:  2012-06-10       Impact factor: 49.962

View more
  63 in total

1.  Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes.

Authors:  Qian Zhu; Mu-Yan Cai; Chang-Long Chen; Hao Hu; Huan-Xin Lin; Min Li; De-Sheng Weng; Jing-Jing Zhao; Ling Guo; Jian-Chuan Xia
Journal:  Oncoimmunology       Date:  2017-04-27       Impact factor: 8.110

Review 2.  The evolution of tumour phylogenetics: principles and practice.

Authors:  Russell Schwartz; Alejandro A Schäffer
Journal:  Nat Rev Genet       Date:  2017-02-13       Impact factor: 53.242

3.  Computational enhancement of single-cell sequences for inferring tumor evolution.

Authors:  Sayaka Miura; Louise A Huuki; Tiffany Buturla; Tracy Vu; Karen Gomez; Sudhir Kumar
Journal:  Bioinformatics       Date:  2018-09-01       Impact factor: 6.937

4.  A cancer associated somatic mutation in LC3B attenuates its binding to E1-like ATG7 protein and subsequent lipidation.

Authors:  Gal Chaim Nuta; Yuval Gilad; Moran Gershoni; Arielle Sznajderman; Tomer Schlesinger; Shani Bialik; Miriam Eisenstein; Shmuel Pietrokovski; Adi Kimchi
Journal:  Autophagy       Date:  2018-10-08       Impact factor: 16.016

5.  Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy.

Authors:  Jeffrey Schlom; Duane H Hamilton; Karin L Lee; Stephen C Benz; Kristin C Hicks; Andrew Nguyen; Sofia R Gameiro; Claudia Palena; John Z Sanborn; Zhen Su; Peter Ordentlich; Lars Rohlin; John H Lee; Shahrooz Rabizadeh; Patrick Soon-Shiong; Kayvan Niazi
Journal:  Cancer Immunol Res       Date:  2019-07-10       Impact factor: 11.151

Review 6.  Genetic insights into the morass of metastatic heterogeneity.

Authors:  Kent W Hunter; Ruhul Amin; Sarah Deasy; Ngoc-Han Ha; Lalage Wakefield
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

7.  Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer.

Authors:  Alvin P Makohon-Moore; Ming Zhang; Johannes G Reiter; Ivana Bozic; Benjamin Allen; Deepanjan Kundu; Krishnendu Chatterjee; Fay Wong; Yuchen Jiao; Zachary A Kohutek; Jungeui Hong; Marc Attiyeh; Breanna Javier; Laura D Wood; Ralph H Hruban; Martin A Nowak; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nat Genet       Date:  2017-01-16       Impact factor: 38.330

Review 8.  Metastasis as a systemic disease: molecular insights and clinical implications.

Authors:  Maša Alečković; Sandra S McAllister; Kornelia Polyak
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-06-14       Impact factor: 10.680

Review 9.  Genetics of metastasis: melanoma and other cancers.

Authors:  Noel Turner; Olivia Ware; Marcus Bosenberg
Journal:  Clin Exp Metastasis       Date:  2018-05-02       Impact factor: 5.150

10.  Data-Independent Acquisition Mass Spectrometry To Quantify Protein Levels in FFPE Tumor Biopsies for Molecular Diagnostics.

Authors:  Yeoun Jin Kim; Steve M M Sweet; Jarrett D Egertson; Andrew J Sedgewick; Sunghee Woo; Wei-Li Liao; Gennifer E Merrihew; Brian C Searle; Charlie Vaske; Robert Heaton; Michael J MacCoss; Todd Hembrough
Journal:  J Proteome Res       Date:  2018-12-12       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.